世界のリバロキサバンAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Rivaroxaban API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL0884 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はリバロキサバンAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。リバロキサバンAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（リバロキサバン錠、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・リバロキサバンAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・リバロキサバンAPIの種類別市場規模：純度≥98％、純度<98％ ・リバロキサバンAPIの用途別市場規模：リバロキサバン錠、その他 ・北米のリバロキサバンAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのリバロキサバンAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのリバロキサバンAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のリバロキサバンAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのリバロキサバンAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Piramal Enterprises Limited、Dr. Reddy's Laboratories、Polpharma S. A.、ZCL Chemicals Limited、Interquim SA、Medichem S.A、UQUIFA、Inke、Tecoland、Teva Pharmaceutical Industries Ltd.、Symed Labs Limited、Unichem Laboratories Limited、Lupin Ltd、Neuland Laboratories、NG ZIP CHEMICAL INDUSTRIAL、Zhejiang Huahai Pharmaceutial. Co., Ltd.、Glenmark Pharmaceuticals、Srini Pharmaceuticals Private Limited、Jiangxi Synergy Pharmaceutical Co., Ltd、Lunan Pharmaceutical Group ・リバロキサバンAPIのバリューチェーン・販売チャネル分析 ・リバロキサバンAPIの世界市場動向

Rivaroxaban belongs to the class of antithrombotic agents. Rivaroxaban reduces a risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischemic attack. It is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

Market Analysis and Insights: Global Rivaroxaban API Market
The global Rivaroxaban API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Rivaroxaban API Scope and Segment
Rivaroxaban API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rivaroxaban API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Rivaroxaban Tablets Others By Company Piramal Enterprises Limited Dr. Reddy's Laboratories Polpharma S. A. ZCL Chemicals Limited Interquim SA Medichem S.A UQUIFA Inke Tecoland Teva Pharmaceutical Industries Ltd. Symed Labs Limited Unichem Laboratories Limited Lupin Ltd Neuland Laboratories NG ZIP CHEMICAL INDUSTRIAL Zhejiang Huahai Pharmaceutial. Co., Ltd. Glenmark Pharmaceuticals Srini Pharmaceuticals Private Limited Jiangxi Synergy Pharmaceutical Co., Ltd Lunan Pharmaceutical Group Production by Region North America Europe China China Taiwan India Israel Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Rivaroxaban API Product Introduction
1.2 Market by Type
1.2.1 Global Rivaroxaban API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Rivaroxaban API Market Size Growth Rate by Application 1.3.2 Rivaroxaban Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Rivaroxaban API Production 2.1 Global Rivaroxaban API Production Capacity (2016-2027) 2.2 Global Rivaroxaban API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Rivaroxaban API Production by Region 2.3.1 Global Rivaroxaban API Historic Production by Region (2016-2021) 2.3.2 Global Rivaroxaban API Forecasted Production by Region (2022-2027) 2.4 North America 2.5 Europe 2.6 China 2.7 China Taiwan 2.8 India 2.9 Israel 3 Global Rivaroxaban API Sales in Volume & Value Estimates and Forecasts 3.1 Global Rivaroxaban API Sales Estimates and Forecasts 2016-2027 3.2 Global Rivaroxaban API Revenue Estimates and Forecasts 2016-2027 3.3 Global Rivaroxaban API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Rivaroxaban API Regions by Sales 3.4.1 Global Top Rivaroxaban API Regions by Sales (2016-2021) 3.4.2 Global Top Rivaroxaban API Regions by Sales (2022-2027) 3.5 Global Top Rivaroxaban API Regions by Revenue 3.5.1 Global Top Rivaroxaban API Regions by Revenue (2016-2021) 3.5.2 Global Top Rivaroxaban API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Rivaroxaban API Production Capacity by Manufacturers 4.2 Global Rivaroxaban API Sales by Manufacturers 4.2.1 Global Top Rivaroxaban API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Rivaroxaban API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Rivaroxaban API Sales in 2020 4.3 Global Rivaroxaban API Revenue by Manufacturers 4.3.1 Global Top Rivaroxaban API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Rivaroxaban API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Rivaroxaban API Revenue in 2020 4.4 Global Rivaroxaban API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Rivaroxaban API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Rivaroxaban API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Rivaroxaban API Sales by Type 5.1.1 Global Rivaroxaban API Historical Sales by Type (2016-2021) 5.1.2 Global Rivaroxaban API Forecasted Sales by Type (2022-2027) 5.1.3 Global Rivaroxaban API Sales Market Share by Type (2016-2027) 5.2 Global Rivaroxaban API Revenue by Type 5.2.1 Global Rivaroxaban API Historical Revenue by Type (2016-2021) 5.2.2 Global Rivaroxaban API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Rivaroxaban API Revenue Market Share by Type (2016-2027) 5.3 Global Rivaroxaban API Price by Type 5.3.1 Global Rivaroxaban API Price by Type (2016-2021) 5.3.2 Global Rivaroxaban API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Rivaroxaban API Sales by Application 6.1.1 Global Rivaroxaban API Historical Sales by Application (2016-2021) 6.1.2 Global Rivaroxaban API Forecasted Sales by Application (2022-2027) 6.1.3 Global Rivaroxaban API Sales Market Share by Application (2016-2027) 6.2 Global Rivaroxaban API Revenue by Application 6.2.1 Global Rivaroxaban API Historical Revenue by Application (2016-2021) 6.2.2 Global Rivaroxaban API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Rivaroxaban API Revenue Market Share by Application (2016-2027) 6.3 Global Rivaroxaban API Price by Application 6.3.1 Global Rivaroxaban API Price by Application (2016-2021) 6.3.2 Global Rivaroxaban API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Rivaroxaban API Market Size by Type 7.1.1 North America Rivaroxaban API Sales by Type (2016-2027) 7.1.2 North America Rivaroxaban API Revenue by Type (2016-2027) 7.2 North America Rivaroxaban API Market Size by Application 7.2.1 North America Rivaroxaban API Sales by Application (2016-2027) 7.2.2 North America Rivaroxaban API Revenue by Application (2016-2027) 7.3 North America Rivaroxaban API Sales by Country 7.3.1 North America Rivaroxaban API Sales by Country (2016-2027) 7.3.2 North America Rivaroxaban API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Rivaroxaban API Market Size by Type 8.1.1 Europe Rivaroxaban API Sales by Type (2016-2027) 8.1.2 Europe Rivaroxaban API Revenue by Type (2016-2027) 8.2 Europe Rivaroxaban API Market Size by Application 8.2.1 Europe Rivaroxaban API Sales by Application (2016-2027) 8.2.2 Europe Rivaroxaban API Revenue by Application (2016-2027) 8.3 Europe Rivaroxaban API Sales by Country 8.3.1 Europe Rivaroxaban API Sales by Country (2016-2027) 8.3.2 Europe Rivaroxaban API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Rivaroxaban API Market Size by Type 9.1.1 Asia Pacific Rivaroxaban API Sales by Type (2016-2027) 9.1.2 Asia Pacific Rivaroxaban API Revenue by Type (2016-2027) 9.2 Asia Pacific Rivaroxaban API Market Size by Application 9.2.1 Asia Pacific Rivaroxaban API Sales by Application (2016-2027) 9.2.2 Asia Pacific Rivaroxaban API Revenue by Application (2016-2027) 9.3 Asia Pacific Rivaroxaban API Sales by Region 9.3.1 Asia Pacific Rivaroxaban API Sales by Region (2016-2027) 9.3.2 Asia Pacific Rivaroxaban API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Rivaroxaban API Market Size by Type 10.1.1 Latin America Rivaroxaban API Sales by Type (2016-2027) 10.1.2 Latin America Rivaroxaban API Revenue by Type (2016-2027) 10.2 Latin America Rivaroxaban API Market Size by Application 10.2.1 Latin America Rivaroxaban API Sales by Application (2016-2027) 10.2.2 Latin America Rivaroxaban API Revenue by Application (2016-2027) 10.3 Latin America Rivaroxaban API Sales by Country 10.3.1 Latin America Rivaroxaban API Sales by Country (2016-2027) 10.3.2 Latin America Rivaroxaban API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Rivaroxaban API Market Size by Type 11.1.1 Middle East and Africa Rivaroxaban API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Rivaroxaban API Revenue by Type (2016-2027) 11.2 Middle East and Africa Rivaroxaban API Market Size by Application 11.2.1 Middle East and Africa Rivaroxaban API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Rivaroxaban API Revenue by Application (2016-2027) 11.3 Middle East and Africa Rivaroxaban API Sales by Country 11.3.1 Middle East and Africa Rivaroxaban API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Rivaroxaban API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Piramal Enterprises Limited 12.1.1 Piramal Enterprises Limited Corporation Information 12.1.2 Piramal Enterprises Limited Overview 12.1.3 Piramal Enterprises Limited Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Piramal Enterprises Limited Rivaroxaban API Product Description 12.1.5 Piramal Enterprises Limited Recent Developments 12.2 Dr. Reddy's Laboratories 12.2.1 Dr. Reddy's Laboratories Corporation Information 12.2.2 Dr. Reddy's Laboratories Overview 12.2.3 Dr. Reddy's Laboratories Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Dr. Reddy's Laboratories Rivaroxaban API Product Description 12.2.5 Dr. Reddy's Laboratories Recent Developments 12.3 Polpharma S. A. 12.3.1 Polpharma S. A. Corporation Information 12.3.2 Polpharma S. A. Overview 12.3.3 Polpharma S. A. Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Polpharma S. A. Rivaroxaban API Product Description 12.3.5 Polpharma S. A. Recent Developments 12.4 ZCL Chemicals Limited 12.4.1 ZCL Chemicals Limited Corporation Information 12.4.2 ZCL Chemicals Limited Overview 12.4.3 ZCL Chemicals Limited Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 ZCL Chemicals Limited Rivaroxaban API Product Description 12.4.5 ZCL Chemicals Limited Recent Developments 12.5 Interquim SA 12.5.1 Interquim SA Corporation Information 12.5.2 Interquim SA Overview 12.5.3 Interquim SA Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Interquim SA Rivaroxaban API Product Description 12.5.5 Interquim SA Recent Developments 12.6 Medichem S.A 12.6.1 Medichem S.A Corporation Information 12.6.2 Medichem S.A Overview 12.6.3 Medichem S.A Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Medichem S.A Rivaroxaban API Product Description 12.6.5 Medichem S.A Recent Developments 12.7 UQUIFA 12.7.1 UQUIFA Corporation Information 12.7.2 UQUIFA Overview 12.7.3 UQUIFA Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 UQUIFA Rivaroxaban API Product Description 12.7.5 UQUIFA Recent Developments 12.8 Inke 12.8.1 Inke Corporation Information 12.8.2 Inke Overview 12.8.3 Inke Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Inke Rivaroxaban API Product Description 12.8.5 Inke Recent Developments 12.9 Tecoland 12.9.1 Tecoland Corporation Information 12.9.2 Tecoland Overview 12.9.3 Tecoland Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 Tecoland Rivaroxaban API Product Description 12.9.5 Tecoland Recent Developments 12.10 Teva Pharmaceutical Industries Ltd. 12.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information 12.10.2 Teva Pharmaceutical Industries Ltd. Overview 12.10.3 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Product Description 12.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments 12.11 Symed Labs Limited 12.11.1 Symed Labs Limited Corporation Information 12.11.2 Symed Labs Limited Overview 12.11.3 Symed Labs Limited Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.11.4 Symed Labs Limited Rivaroxaban API Product Description 12.11.5 Symed Labs Limited Recent Developments 12.12 Unichem Laboratories Limited 12.12.1 Unichem Laboratories Limited Corporation Information 12.12.2 Unichem Laboratories Limited Overview 12.12.3 Unichem Laboratories Limited Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.12.4 Unichem Laboratories Limited Rivaroxaban API Product Description 12.12.5 Unichem Laboratories Limited Recent Developments 12.13 Lupin Ltd 12.13.1 Lupin Ltd Corporation Information 12.13.2 Lupin Ltd Overview 12.13.3 Lupin Ltd Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.13.4 Lupin Ltd Rivaroxaban API Product Description 12.13.5 Lupin Ltd Recent Developments 12.14 Neuland Laboratories 12.14.1 Neuland Laboratories Corporation Information 12.14.2 Neuland Laboratories Overview 12.14.3 Neuland Laboratories Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.14.4 Neuland Laboratories Rivaroxaban API Product Description 12.14.5 Neuland Laboratories Recent Developments 12.15 NG ZIP CHEMICAL INDUSTRIAL 12.15.1 NG ZIP CHEMICAL INDUSTRIAL Corporation Information 12.15.2 NG ZIP CHEMICAL INDUSTRIAL Overview 12.15.3 NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.15.4 NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Product Description 12.15.5 NG ZIP CHEMICAL INDUSTRIAL Recent Developments 12.16 Zhejiang Huahai Pharmaceutial. Co., Ltd. 12.16.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Corporation Information 12.16.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Overview 12.16.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.16.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Product Description 12.16.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments 12.17 Glenmark Pharmaceuticals 12.17.1 Glenmark Pharmaceuticals Corporation Information 12.17.2 Glenmark Pharmaceuticals Overview 12.17.3 Glenmark Pharmaceuticals Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.17.4 Glenmark Pharmaceuticals Rivaroxaban API Product Description 12.17.5 Glenmark Pharmaceuticals Recent Developments 12.18 Srini Pharmaceuticals Private Limited 12.18.1 Srini Pharmaceuticals Private Limited Corporation Information 12.18.2 Srini Pharmaceuticals Private Limited Overview 12.18.3 Srini Pharmaceuticals Private Limited Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.18.4 Srini Pharmaceuticals Private Limited Rivaroxaban API Product Description 12.18.5 Srini Pharmaceuticals Private Limited Recent Developments 12.19 Jiangxi Synergy Pharmaceutical Co., Ltd 12.19.1 Jiangxi Synergy Pharmaceutical Co., Ltd Corporation Information 12.19.2 Jiangxi Synergy Pharmaceutical Co., Ltd Overview 12.19.3 Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.19.4 Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Product Description 12.19.5 Jiangxi Synergy Pharmaceutical Co., Ltd Recent Developments 12.20 Lunan Pharmaceutical Group 12.20.1 Lunan Pharmaceutical Group Corporation Information 12.20.2 Lunan Pharmaceutical Group Overview 12.20.3 Lunan Pharmaceutical Group Rivaroxaban API Sales, Price, Revenue and Gross Margin (2016-2021) 12.20.4 Lunan Pharmaceutical Group Rivaroxaban API Product Description 12.20.5 Lunan Pharmaceutical Group Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Rivaroxaban API Industry Chain Analysis 13.2 Rivaroxaban API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Rivaroxaban API Production Mode & Process 13.4 Rivaroxaban API Sales and Marketing 13.4.1 Rivaroxaban API Sales Channels 13.4.2 Rivaroxaban API Distributors 13.5 Rivaroxaban API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Rivaroxaban API Industry Trends 14.2 Rivaroxaban API Market Drivers 14.3 Rivaroxaban API Market Challenges 14.4 Rivaroxaban API Market Restraints 15 Key Finding in The Global Rivaroxaban API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Rivaroxaban API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Rivaroxaban API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Rivaroxaban API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Rivaroxaban API Production by Region (2016-2021) & (Ton)
Table 7. Global Rivaroxaban API Production Market Share by Region (2016-2021)
Table 8. Global Rivaroxaban API Production by Region (2022-2027) & (Ton)
Table 9. Global Rivaroxaban API Production Market Share by Region (2022-2027)
Table 10. Global Rivaroxaban API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Rivaroxaban API Sales by Region (2016-2021) & (Ton)
Table 12. Global Rivaroxaban API Sales Market Share by Region (2016-2021)
Table 13. Global Rivaroxaban API Sales by Region (2022-2027) & (Ton)
Table 14. Global Rivaroxaban API Sales Market Share by Region (2022-2027)
Table 15. Global Rivaroxaban API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Rivaroxaban API Revenue Market Share by Region (2016-2021)
Table 17. Global Rivaroxaban API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Rivaroxaban API Revenue Market Share by Region (2022-2027)
Table 19. Global Rivaroxaban API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Rivaroxaban API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Rivaroxaban API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Rivaroxaban API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Rivaroxaban API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Rivaroxaban API Sales Share by Manufacturers (2016-2021)
Table 25. Global Rivaroxaban API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Rivaroxaban API Revenue Share by Manufacturers (2016-2021)
Table 27. Rivaroxaban API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Rivaroxaban API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Rivaroxaban API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rivaroxaban API as of 2020)
Table 30. Rivaroxaban API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Rivaroxaban API Product Offered
Table 32. Date of Manufacturers Enter into Rivaroxaban API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Rivaroxaban API Sales by Type (2016-2021) & (Ton)
Table 35. Global Rivaroxaban API Sales by Type (2022-2027) & (Ton)
Table 36. Global Rivaroxaban API Sales Share by Type (2016-2021)
Table 37. Global Rivaroxaban API Sales Share by Type (2022-2027)
Table 38. Global Rivaroxaban API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Rivaroxaban API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Rivaroxaban API Revenue Share by Type (2016-2021)
Table 41. Global Rivaroxaban API Revenue Share by Type (2022-2027)
Table 42. Rivaroxaban API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Rivaroxaban API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Rivaroxaban API Sales by Application (2016-2021) & (Ton)
Table 45. Global Rivaroxaban API Sales by Application (2022-2027) & (Ton)
Table 46. Global Rivaroxaban API Sales Share by Application (2016-2021)
Table 47. Global Rivaroxaban API Sales Share by Application (2022-2027)
Table 48. Global Rivaroxaban API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Rivaroxaban API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Rivaroxaban API Revenue Share by Application (2016-2021)
Table 51. Global Rivaroxaban API Revenue Share by Application (2022-2027)
Table 52. Rivaroxaban API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Rivaroxaban API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Rivaroxaban API Sales by Type (2016-2021) & (Ton)
Table 55. North America Rivaroxaban API Sales by Type (2022-2027) & (Ton)
Table 56. North America Rivaroxaban API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Rivaroxaban API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Rivaroxaban API Sales by Application (2016-2021) & (Ton)
Table 59. North America Rivaroxaban API Sales by Application (2022-2027) & (Ton)
Table 60. North America Rivaroxaban API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Rivaroxaban API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Rivaroxaban API Sales by Country (2016-2021) & (Ton)
Table 63. North America Rivaroxaban API Sales by Country (2022-2027) & (Ton)
Table 64. North America Rivaroxaban API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Rivaroxaban API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Rivaroxaban API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Rivaroxaban API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Rivaroxaban API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Rivaroxaban API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Rivaroxaban API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Rivaroxaban API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Rivaroxaban API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Rivaroxaban API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Rivaroxaban API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Rivaroxaban API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Rivaroxaban API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Rivaroxaban API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Rivaroxaban API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Rivaroxaban API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Rivaroxaban API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Rivaroxaban API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Rivaroxaban API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Rivaroxaban API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Rivaroxaban API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Rivaroxaban API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Rivaroxaban API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Rivaroxaban API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Rivaroxaban API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Rivaroxaban API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Rivaroxaban API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Rivaroxaban API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Rivaroxaban API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Rivaroxaban API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Rivaroxaban API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Rivaroxaban API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Rivaroxaban API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Rivaroxaban API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Rivaroxaban API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Rivaroxaban API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Rivaroxaban API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Rivaroxaban API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Rivaroxaban API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Rivaroxaban API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Rivaroxaban API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Rivaroxaban API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Rivaroxaban API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Rivaroxaban API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Rivaroxaban API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Rivaroxaban API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Rivaroxaban API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Rivaroxaban API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Rivaroxaban API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Rivaroxaban API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Piramal Enterprises Limited Corporation Information
Table 115. Piramal Enterprises Limited Description and Major Businesses
Table 116. Piramal Enterprises Limited Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Piramal Enterprises Limited Rivaroxaban API Product
Table 118. Piramal Enterprises Limited Recent Development
Table 119. Dr. Reddy's Laboratories Corporation Information
Table 120. Dr. Reddy's Laboratories Description and Major Businesses
Table 121. Dr. Reddy's Laboratories Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Dr. Reddy's Laboratories Rivaroxaban API Product
Table 123. Dr. Reddy's Laboratories Recent Development
Table 124. Polpharma S. A. Corporation Information
Table 125. Polpharma S. A. Description and Major Businesses
Table 126. Polpharma S. A. Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Polpharma S. A. Rivaroxaban API Product
Table 128. Polpharma S. A. Recent Development
Table 129. ZCL Chemicals Limited Corporation Information
Table 130. ZCL Chemicals Limited Description and Major Businesses
Table 131. ZCL Chemicals Limited Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. ZCL Chemicals Limited Rivaroxaban API Product
Table 133. ZCL Chemicals Limited Recent Development
Table 134. Interquim SA Corporation Information
Table 135. Interquim SA Description and Major Businesses
Table 136. Interquim SA Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Interquim SA Rivaroxaban API Product
Table 138. Interquim SA Recent Development
Table 139. Medichem S.A Corporation Information
Table 140. Medichem S.A Description and Major Businesses
Table 141. Medichem S.A Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Medichem S.A Rivaroxaban API Product
Table 143. Medichem S.A Recent Development
Table 144. UQUIFA Corporation Information
Table 145. UQUIFA Description and Major Businesses
Table 146. UQUIFA Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. UQUIFA Rivaroxaban API Product
Table 148. UQUIFA Recent Development
Table 149. Inke Corporation Information
Table 150. Inke Description and Major Businesses
Table 151. Inke Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Inke Rivaroxaban API Product
Table 153. Inke Recent Development
Table 154. Tecoland Corporation Information
Table 155. Tecoland Description and Major Businesses
Table 156. Tecoland Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. Tecoland Rivaroxaban API Product
Table 158. Tecoland Recent Development
Table 159. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 160. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 161. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Product
Table 163. Teva Pharmaceutical Industries Ltd. Recent Development
Table 164. Symed Labs Limited Corporation Information
Table 165. Symed Labs Limited Description and Major Businesses
Table 166. Symed Labs Limited Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 167. Symed Labs Limited Rivaroxaban API Product
Table 168. Symed Labs Limited Recent Development
Table 169. Unichem Laboratories Limited Corporation Information
Table 170. Unichem Laboratories Limited Description and Major Businesses
Table 171. Unichem Laboratories Limited Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 172. Unichem Laboratories Limited Rivaroxaban API Product
Table 173. Unichem Laboratories Limited Recent Development
Table 174. Lupin Ltd Corporation Information
Table 175. Lupin Ltd Description and Major Businesses
Table 176. Lupin Ltd Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 177. Lupin Ltd Rivaroxaban API Product
Table 178. Lupin Ltd Recent Development
Table 179. Neuland Laboratories Corporation Information
Table 180. Neuland Laboratories Description and Major Businesses
Table 181. Neuland Laboratories Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 182. Neuland Laboratories Rivaroxaban API Product
Table 183. Neuland Laboratories Recent Development
Table 184. NG ZIP CHEMICAL INDUSTRIAL Corporation Information
Table 185. NG ZIP CHEMICAL INDUSTRIAL Description and Major Businesses
Table 186. NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 187. NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Product
Table 188. NG ZIP CHEMICAL INDUSTRIAL Recent Development
Table 189. Zhejiang Huahai Pharmaceutial. Co., Ltd. Corporation Information
Table 190. Zhejiang Huahai Pharmaceutial. Co., Ltd. Description and Major Businesses
Table 191. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 192. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Product
Table 193. Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Development
Table 194. Glenmark Pharmaceuticals Corporation Information
Table 195. Glenmark Pharmaceuticals Description and Major Businesses
Table 196. Glenmark Pharmaceuticals Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 197. Glenmark Pharmaceuticals Rivaroxaban API Product
Table 198. Glenmark Pharmaceuticals Recent Development
Table 199. Srini Pharmaceuticals Private Limited Corporation Information
Table 200. Srini Pharmaceuticals Private Limited Description and Major Businesses
Table 201. Srini Pharmaceuticals Private Limited Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 202. Srini Pharmaceuticals Private Limited Rivaroxaban API Product
Table 203. Srini Pharmaceuticals Private Limited Recent Development
Table 204. Jiangxi Synergy Pharmaceutical Co., Ltd Corporation Information
Table 205. Jiangxi Synergy Pharmaceutical Co., Ltd Description and Major Businesses
Table 206. Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 207. Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Product
Table 208. Jiangxi Synergy Pharmaceutical Co., Ltd Recent Development
Table 209. Lunan Pharmaceutical Group Corporation Information
Table 210. Lunan Pharmaceutical Group Description and Major Businesses
Table 211. Lunan Pharmaceutical Group Rivaroxaban API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 212. Lunan Pharmaceutical Group Rivaroxaban API Product
Table 213. Lunan Pharmaceutical Group Recent Development
Table 214. Key Raw Materials Lists
Table 215. Raw Materials Key Suppliers Lists
Table 216. Rivaroxaban API Distributors List
Table 217. Rivaroxaban API Customers List
Table 218. Rivaroxaban API Market Trends
Table 219. Rivaroxaban API Market Drivers
Table 220. Rivaroxaban API Market Challenges
Table 221. Rivaroxaban API Market Restraints
Table 222. Research Programs/Design for This Report
Table 223. Key Data Information from Secondary Sources
Table 224. Key Data Information from Primary Sources
List of Figures
Figure 1. Rivaroxaban API Product Picture
Figure 2. Global Rivaroxaban API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Rivaroxaban API Market Share by Application in 2020 & 2027
Figure 6. Rivaroxaban Tablets
Figure 7. Others
Figure 8. Rivaroxaban API Report Years Considered
Figure 9. Global Rivaroxaban API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Rivaroxaban API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Rivaroxaban API Production Market Share by Region (2016-2021)
Figure 12. Global Rivaroxaban API Production Market Share by Region (2022-2027)
Figure 13. Rivaroxaban API Production Growth Rate in North America (2016-2027) & (Ton)
Figure 14. Rivaroxaban API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Rivaroxaban API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Rivaroxaban API Production Growth Rate in China Taiwan (2016-2027) & (Ton)
Figure 17. Rivaroxaban API Production Growth Rate in India (2016-2027) & (Ton)
Figure 18. Rivaroxaban API Production Growth Rate in Israel (2016-2027) & (Ton)
Figure 19. Global Rivaroxaban API Sales 2016-2027 (Ton)
Figure 20. Global Rivaroxaban API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 21. Global Rivaroxaban API Revenue 2016-2027 (US$ Million)
Figure 22. Global Rivaroxaban API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 23. Global Rivaroxaban API Sales Market Share by Region (2016-2021)
Figure 24. Global Rivaroxaban API Sales Market Share by Region (2022-2027)
Figure 25. North America Rivaroxaban API Sales YoY (2016-2027) & (Ton)
Figure 26. North America Rivaroxaban API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Europe Rivaroxaban API Sales YoY (2016-2027) & (Ton)
Figure 28. Europe Rivaroxaban API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Asia-Pacific Rivaroxaban API Sales YoY (2016-2027) & (Ton)
Figure 30. Asia-Pacific Rivaroxaban API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Latin America Rivaroxaban API Sales YoY (2016-2027) & (Ton)
Figure 32. Latin America Rivaroxaban API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. Middle East & Africa Rivaroxaban API Sales YoY (2016-2027) & (Ton)
Figure 34. Middle East & Africa Rivaroxaban API Revenue YoY (2016-2027) & (US$ Million)
Figure 35. The Top 10 and Top 5 Players Market Share by Rivaroxaban API Sales in 2020
Figure 36. The Top 10 and Top 5 Players Market Share by Rivaroxaban API Revenue in 2020
Figure 37. Rivaroxaban API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 38. Global Rivaroxaban API Sales Market Share by Type (2016-2027)
Figure 39. Global Rivaroxaban API Revenue Market Share by Type (2016-2027)
Figure 40. Global Rivaroxaban API Sales Market Share by Application (2016-2027)
Figure 41. Global Rivaroxaban API Revenue Market Share by Application (2016-2027)
Figure 42. North America Rivaroxaban API Sales Market Share by Type (2016-2027)
Figure 43. North America Rivaroxaban API Revenue Market Share by Type (2016-2027)
Figure 44. North America Rivaroxaban API Sales Market Share by Application (2016-2027)
Figure 45. North America Rivaroxaban API Revenue Market Share by Application (2016-2027)
Figure 46. North America Rivaroxaban API Sales Share by Country (2016-2027)
Figure 47. North America Rivaroxaban API Revenue Share by Country (2016-2027)
Figure 48. United States Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 49. Canada Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 50. Europe Rivaroxaban API Sales Market Share by Type (2016-2027)
Figure 51. Europe Rivaroxaban API Revenue Market Share by Type (2016-2027)
Figure 52. Europe Rivaroxaban API Sales Market Share by Application (2016-2027)
Figure 53. Europe Rivaroxaban API Revenue Market Share by Application (2016-2027)
Figure 54. Europe Rivaroxaban API Sales Share by Country (2016-2027)
Figure 55. Europe Rivaroxaban API Revenue Share by Country (2016-2027)
Figure 56. Germany Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 57. France Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 58. U.K. Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 59. Italy Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 60. Russia Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 61. Asia Pacific Rivaroxaban API Sales Market Share by Type (2016-2027)
Figure 62. Asia Pacific Rivaroxaban API Revenue Market Share by Type (2016-2027)
Figure 63. Asia Pacific Rivaroxaban API Sales Market Share by Application (2016-2027)
Figure 64. Asia Pacific Rivaroxaban API Revenue Market Share by Application (2016-2027)
Figure 65. Asia Pacific Rivaroxaban API Sales Share by Region (2016-2027)
Figure 66. Asia Pacific Rivaroxaban API Revenue Share by Region (2016-2027)
Figure 67. China Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 68. Japan Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 69. South Korea Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 70. India Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 71. Australia Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 72. China Taiwan Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 73. Indonesia Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 74. Thailand Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 75. Malaysia Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 76. Latin America Rivaroxaban API Sales Market Share by Type (2016-2027)
Figure 77. Latin America Rivaroxaban API Revenue Market Share by Type (2016-2027)
Figure 78. Latin America Rivaroxaban API Sales Market Share by Application (2016-2027)
Figure 79. Latin America Rivaroxaban API Revenue Market Share by Application (2016-2027)
Figure 80. Latin America Rivaroxaban API Sales Share by Country (2016-2027)
Figure 81. Latin America Rivaroxaban API Revenue Share by Country (2016-2027)
Figure 82. Mexico Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 83. Brazil Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 84. Argentina Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 85. Middle East and Africa Rivaroxaban API Sales Market Share by Type (2016-2027)
Figure 86. Middle East and Africa Rivaroxaban API Revenue Market Share by Type (2016-2027)
Figure 87. Middle East and Africa Rivaroxaban API Sales Market Share by Application (2016-2027)
Figure 88. Middle East and Africa Rivaroxaban API Revenue Market Share by Application (2016-2027)
Figure 89. Middle East and Africa Rivaroxaban API Sales Share by Country (2016-2027)
Figure 90. Middle East and Africa Rivaroxaban API Revenue Share by Country (2016-2027)
Figure 91. Turkey Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 92. Saudi Arabia Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 93. UAE Rivaroxaban API Revenue (2016-2027) & (US$ Million)
Figure 94. Rivaroxaban API Value Chain
Figure 95. Rivaroxaban API Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

---